Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?
Alzheimer’s disease (AD), as a neurodegenerative disorder, usually develops slowly but gradually worsens. It accounts for approximately 70% of dementia cases worldwide, and is recognized by WHO as a public health priority. Being a multifactorial disease, the origins of AD are not satisfactorily unde...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Revisão |
| Idioma: | anglès |
| Publicat: |
2023
|
| Accés en línia: | https://doi.org/10.3390/pharmaceutics15030916 https://www.mdpi.com/1999-4923/15/3/916/pdf?version=1678689773 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|